Discovery & Progress of ZN-c3, a Highly Potent & Selective WEE1 Inhibitor Undergoing Evaluation in Clinical Trials for the Treatment of Cancer
Time: 11:30 am
day: Day One
Details:
- Discovery of ZN-c3 as a potent and selective Wee1 inhibitor
- Exploring ZN-c3 antitumor effect as a single agent and in combination
- Diving into recent ZN-c3 clinical data
